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Background: Currently it is uncertain how to define osteoporosis and who to treat after a hip fracture. There is
little to support the universal treatment of all such patients but how to select those most in need of treatment is
not clear. In this study we have compared cortical and trabecular bone status between patients with spinal
fractures and those with hip fracture with or without spinal fracture with the aim to begin to identify, by a simple
clinical method (spine x-ray), a group of hip fracture patients likely to be more responsive to treatment with current
antiresorptive agents.
Methods: Comparison of convenience samples of three groups of 50 patients, one with spinal fractures, one with a
hip fracture, and one with both. Measurements consist of bone mineral density at the lumbar spine, at the four
standard hip sites, number, distribution and severity of spinal fractures by the method of Genant, cortical bone
thickness at the infero-medial femoral neck site, femoral neck and axis length and femoral neck width.
Results: Patients with spinal fractures alone have the most deficient bones at both trabecular and cortical sites:
those with hip fracture and no spinal fractures the best at trabecular bone and most cortical bone sites: and those
with both hip and spinal fractures intermediate in most measurements. Hip axis length and neck width did not
differ between groups.
Conclusion: The presence of the spinal fracture indicates poor trabecular bone status in hip fracture patients. Hip
fracture patients without spinal fractures have a bone mass similar to the reference range for their age and gender.
Poor trabecular bone in hip fracture patients may point to a category of patient more likely to benefit from therapy
and may be indicated by the presence of spinal fractures.
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In the evaluation of medications for osteoporosis the es-
sential requirement is the prevention of fractures. Al-
though initially the focus was on the prevention of
compression fractures of the spine, the importance of
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reproduction in any medium, provided the ora critical expectation of the drugs. Without exception,
however, the therapies are better at preventing spinal
fractures than non-spinal fractures, possibly because
they are more effective on trabecular bone than cortical
bone, the latter being an important contributor to the
strength of the non-spinal fracture sites [1]. Despite this,
the focus has shifted from osteoporosis as a disease of
trabecular bone resulting in spinal fractures, to a state of
risk of fracture, with a focus on non-vertebral, substan-
tially cortical bone fractures that occur in a fall. The
non-vertebral fractures now dominate the fracture risk
assessment paradigms which are based on measuresl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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oral neck density [2,3].
By and large, it seems that patients at the lower end of
the normal distribution of bone densities in the general
population, are, should they fall, at greater risk of frac-
ture than those at the upper end of the distribution. For
example, in the EPIDOS study of women average age of
80 years, those with BMD on heel ultrasound and neck
of femur BMD that were below average had a risk of hip
fracture of 1.96% per year compared to 0.27% if above
average [4].
In addition to simple bone thinning with age, some
architectural features of the neck of femur might be im-
portant in determining risk of hip fracture. Differences
in hip bone density, mostly at the neck of femur site,
and differences in architecture (Singh index) and geom-
etry (hip axis length, neck-shaft angle) of the proximal
femur between those with a hip fracture and normal
controls have been described [5-9]. An additional issue
is the design of the bone and whether it is being exposed
to a force for which it was not designed [10]. Thus the
trabecular pattern of the femur is arranged to withstand
loading from above and not to withstand a blow on the
greater trochanter from the side, as occurs in falls in the
elderly and which generates a force that greatly exceeds
the strength of any hip [11]. It is likely that many of the
structural differences between hip fracture patients and
others will be unresponsive to treatment with current
osteoporosis medications.
By contrast, spinal fractures do not usually require a fall
and can be sustained in normal activity. Indeed, the verte-
bral fracture is to some extent distinguished from the non-
vertebral fracture in that it usually occurs under a force
the vertebra should have been able to withstand, in con-
trast to the non-vertebral fracture where more is expected
of the bone than it was designed to meet. Nonetheless,
these non-vertebral fractures have come to be considered
fragility fractures, and have come to be considered indica-
tive of osteoporosis, although they are best predicted by a
measure of cortical bone. Nonetheless, most of the clinical
trials, predominantly with bisphosphonates, were done on
people many or most of whom had spinal compression
fractures and better fitted the trabecular bone loss model.
These patients displayed anything up to 13% chance of a
new spinal fracture within a year, higher if there had been
a recent compression fracture, but a lesser degree of
increased risk of non-vertebral fracture [12]. Thus it
appears that the loss of trabecular bone puts the spine par-
ticularly at risk, but only partly compromises the non-
vertebral sites. Consistently, the fractures which respond
best to treatment are the spinal fractures of trabecular
bone. Possibly the degree of trabecular bone deficiency at
a specific site may determine the degree of response that
can be expected from treatment.The question arises, when does the spinal fracture syn-
drome merge into or overlap with the mechanical model
of low trauma fracture? Is there, at one end of the scale,
the patient with a hip fracture who has deficient tra-
becular bone while at the other end the patient with
perhaps some loss of cortical bone but in whom the
fracture is mostly traumatic and where response to treat-
ment is likely to be minimal? In other words, does the
degree of trabecular bone deficiency indicate a state
more likely to respond to treatment and how can these
patients be identified? If, for example, hip fracture pa-
tients have compression fractures, is this on the basis of
low trabecular bone mass, or are these also largely trau-
matic? If the former, this may point to a state of defi-
cient trabecular bone mass throughout the skeleton, but
if largely traumatic or mechanical in nature, bone mass
may not be much reduced but we might expect a differ-
ent distribution of spinal fractures, more being low in
the lumbar spine, the site most vulnerable in a fall or
accident [13].
To begin to explore this possibility we have, in this
study, compared, on the basis of trabecular and cortical
measurements, three approximately age-matched groups
of older patients with osteoporotic-type fractures
consisting of; patients attending an out-patient osteopor-
osis clinic referred because of the presence of compres-
sion fractures (but with no history of hip fracture);
patients admitted to a hip fracture rehabilitation pro-
gram who, upon spinal x-ray, were found to have com-
pression fractures; and similar patients found not to
have compression fractures. The first group is proposed
as the gold standard for the presence of severe trabecu-
lar bone loss, the second, hip and spinal fracture patients
as potentially having trabecular osteoporosis (as the
spinal fracture could, itself, be traumatic and caused by
falling) and the third, those with only a hip fracture, as
potentially non-osteoporotic traumatic fracture patients.
Methods
Patient selection
This was a retrospective data review of patients mostly
over the age of 70 years presenting to an osteoporosis
clinic with spinal compression fractures but no history
of hip fracture and those admitted to a rehabilitation
unit following a hip fracture. All patients had a standard
osteoporosis series of radiographs performed, consisting
of a lateral and AP view of the thoracic and lumbar
spine and AP view of the pelvis, all in digital form. All
patients underwent bone mineral density at spine and
hip sites. Hip fracture patients from long term care, and
those who are admitted directly to LTC from the ortho-
pedic unit, are not transferred to the rehabilitation pro-
gram and are not represented in this study. These
patients are older than the population studied here.
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ectly home following surgery do not come to the re-
habilitation program and are also not represented here.
For this study there are a total of 150 patients compris-
ing 50 patients from each of three patient groups, viz.
patients from the osteoporosis clinic with compression
fractures and no history of hip fracture, patients from the
hip fracture rehabilitation population who were found to
have spinal compression fractures on x-ray, and patients
with a hip fracture but no spinal fracture. Patients were
required to have had: (1) BMD; (2) radiographic images of
the thoracic and lumbar spine; and (3) radiographic image
of the pelvis with at least one clean hip joint (no prosthetic
or replacement device).
Several variables were examined as follows:
BMD
The BMD for the spine (L2-L4), the total hip, the
intertrochanteric region, the trochanteric and the neck of
the proximal femur were recorded. All BMDs were
obtained using dual-energy x-ray absorptiometry (DEXA).
For each region tested the BMD value (g/cm2), t-score
and z-score were recorded. The z-score is the degree in
standard deviation units by which the individual differs
from the mean level for their age and sex as compared to
the normative data base for the specific BMD machine.
We use this comparison to determine if the individuals
and groups are similar or otherwise to the normal popula-
tion. The spine site is predominantly a measure of tra-
becular bone (66%), the neck of femur site predominantly
cortical bone (75%) while the intertrochanteric site is
about 50% trabecular and 50% cortical [1]. In the follow-
ing we refer to the spine as a trabecular bone site and the
neck of femur as a cortical bone site though none is exclu-
sively one or the other.
The location and severity of vertebral fractures
Radiographic images of the lateral vertebral column were
recorded, graded, and analyzed based on Genant et al.’s
semiquantitative assessment of vertebral fractures [14].
This method assesses the presence and severity of a
fracture by visual determination. The degree of height
reduction determines the grade (0, 1, 2 or 3) assigned to
each vertebra from T4 to L4.
The Spinal Fracture Index used Genant’s semiquan-
titative assessment for each vertebrae from T4-L4 [14].
The radiographic image of each vertebrae is visually
assessed and given a grade based on the level of deform-
ity (Grade 0 = No visible deformity; Grade 1 = 20-25%
deformity; Grade 2 = 25-40% deformity; Grade 3 = more
than 40% deformity). The scores for each vertebrae from
T4-L4 are then summed and divided by 13 to get an aver-
age SFI for the patient. The Spinal Deformity Index (SDI)
is derived from Genant’s semiquantitative assessment todescribe the total fracture status of the spine. The SDI is
calculated for each patient by summing the vertebral
fracture grades (0, 1, 2 or 3) from T4 to L4 (14).
As spinal BMD is influenced by the presence of spinal
degenerative disease, we recorded this when it was
provided by the formal radiology report which was done
by radiologists unaware of this study.
Hip axis length, femoral neck length and femoral neck
cortical bone thickness were measured as outlined by
Peacock and colleagues [5]. Briefly, the femoral axis
length measures from the lateral point of the femur
where the greater trochanter joins the shaft to the centre
apex of the femoral head. The hip axis length extends
that measurement to the inner (pelvic) surface of the
acetabulum. Femoral neck width was measured in ac-
cordance with that reported by Karlsson and colleagues
and is the narrowest point of the femoral neck [15].
Statistical analysis was performed using IBMSPSS
Statistics Software version 19. The SPSS Test of Normal-
ity employed was the Shapiro-Wilk Test which indicated
normality for all parameters except trochanteric BMD,
femoral neck BMD, femoral neck width and hip axis
length for which the Mann–Whitney U test was used to
compare groups rather than the t-test used for the
others.
Ethics approval was obtained through the University
of Western Ontario Ethics Board.
Results
Table 1 outlines the characteristics of patients presenting
to a specialized osteoporosis clinic with compression
fractures (N=50; mean age = 76.56+/−9.34 years; 14
men) and those of similar age and gender presenting
with hip fracture (both intertrochanteric and subcapital
types) half of whom were selected for the presence of
compression fractures (N=50; mean age =79.46+/−6.45
years; 12 men) and half for their absence (N=50; mean
age=81.00+/−5.89 years; 9 men).
BMD
Patients with only spinal fractures had a significantly
lower lumbar t-score than those presenting with hip
fractures (with or without spinal fractures) (−2.54 vs. -1.27
p<0.001). Twenty-three, 16 and 23 spinal fracture only
patients, hip and spinal fracture patients and hip fracture
only patients respectively had degenerative changes noted
on the x-ray report and 9, 8, and 7 of these respectively
were reported as showing sclerosis, but the spinal BMD
was not higher in these patients and their exclusion did
not affect the results. Spinal fracture only patients also
have a tendency to a lower hip density, reaching signifi-
cance only for the intertrochanteric (50% trabecular
bone) region (−2.17 vs −1.70 p< 0.05 (Table 1)). Gener-
ally, those individuals presenting with only vertebral
Table 1 Comparison of the three groups
Characteristic Only spinal fractures Spinal & hip fractures Only hip fractures All hip fractures
(N=50) (N=50) (N=50) (N=100)
Women 36 38 41 79
Men 14 12 9 21
Age, mean +/- SD 76.6+/- 9.3+# 79.5+/- 6.5 81.0+/- 5.9+ 80.2+/- 6.2#
Age, Range 52-92 65-91 66-89 65-91
Lumbar BMD Results, mean +/- SD 0.801+/-0.178*+# 0.913+/-0.176* 0.967+/-0.205+ 0.940+/-0.192#
Lumbar T-Score, mean +/- SD -2.539+/-1.551*+# -1.578+/-1.542* -0.956+/-1.832+ -1.265+/-1.713#
Lumbar Z-Score, mean +/- SD -0.461+/-2.003*+# 0.533+/-1.442* 1.233+/-2.029+ 0.864+/-1.767#
Total Hip BMD Results, mean +/- SD 0.666+/-0.174 0.703+/-0.143 0.727+/-0.136 0.716+/-0.139
Total Hip T-Score, mean +/- SD -2.251+/-1.457 -1.946+/-1.319 -1.866+/-0.999 -1.905+/-1.163
Total Hip Z-Score, mean +/- SD -0.577+/-1.286 -0.420+/-1.128 -0.102+/-1.012 -0.268+/-1.078
Intertrochanteric Hip BMD Results, mean +/- SD 0.773+/-0.211+# 0.825+/-0.164 0.864+/-0.167+ 0.845+/-0.166#
Intertrochanteric Hip T-Score, mean +/- SD -2.168+/-1.261+# -1.855+/-0.979 -1.552+/-0.890+ -1.703+/-0.942#
Intertrochanteric Hip Z-Score, mean +/- SD -0.646+/-1.309+ -0.421+/-1.076~ 0.142+/-0.999+~ -0.152+/-1.070
Trochanteric BMD Results, mean +/- SD 0.510+/-0.145 0.547+/-0.142 0.556+/-0.133 0.552+/-0.137
Trochanteric T-Score, mean +/- SD -2.026+/-1.278 -1.686+/-1.188 -1.573+/-1.192 -1.630+/-1.184
Trochanteric Z-Score, mean +/- SD -0.614+/-1.322+ -0.353+/-1.098 0.035+/-1.106+ -0.168+/-1.111
Femoral Neck BMD Results, mean +/- SD 0.561+/-0.125 0.590+/-0.103 0.607+/-0.122 0.599+/-0.112#
Femoral Neck T-Score, mean +/- SD -2.681+/-1.057*# -2.177+/-1.245* -2.273+/-0.935 -2.225+/-1.095#
Femoral Neck Z-Score, mean +/- SD -0.622+/-0.910+ -0.450+/-1.027 -0.077+/-1.044+ -0.272+/-1.044
Hip Axis Length, mm, mean +/- SD 126.91+/-12.55 129.52+/-11.03 128.84+/-11.48 129.18+/-11.21
Femoral Neck Length, mm, mean +/- SD 111.06+/-9.97 112.66+/-8.67 112.43+/-9.00 112.55+/-8.79
Femoral Neck Width, mm, mean +/- SD 37.93+/-4.49 38.77+/-4.01 38.15+/-3.86 38.46+/-3.93
Cortical Bone Thickness, mm, mean +/- SD 4.09+/-0.75*+# 4.77+/-0.95* 4.55+/-1.15+ 4.66+/-1.06#
* indicates significant differences (p < 0.05) between the 'Only Spinal Fractures' group and the 'Spinal and Hip Fractures' group.
+ indicates significant differences (p < 0.05) between the 'Only Spinal Fractures' group and the ‘Only Hip Fractures' group.
# indicates significant differences (p < 0.05) between the 'Only Spinal Fractures' group and the ‘All Hip Fracture’ group.
~ indicates significant differences (p < 0.05) between the ‘Spinal and Hip Fractures' group and the ‘Only Hip Fractures' group.
Crilly and Cox BMC Musculoskeletal Disorders 2013, 14:68 Page 4 of 9
http://www.biomedcentral.com/1471-2474/14/68fractures have a lower BMD t-score at all sites than
those presenting with hip and spinal fractures, who, in
turn, have a lower BMD t-score than those presenting
with only hip fractures and no spinal fractures
(Figure 1). The femoral neck t-score is the only region
that does not follow this trend. Similarly, direct meas-
urement of the femoral infero-medial cortical bone
thickness shows it to be lower in the spinal fracture
only patients as compared to both hip fracture groups
combined (4.09 vs.4.66mm: p<0.001). The two hip frac-
ture groups, with or without spinal fractures, have simi-
lar cortical thickness (Figure 2). Comparison of the two
hip fracture groups shows that those with a spinal frac-
ture have lower trabecular site t-scores (spine, total hip,
intertrochanteric and trochanteric) but similar cortical
bone measurements (neck of femur and cortical bone
thickness) though none of the comparisons reached
significance (Table 1).
Cortical bone thickness correlates significantly with
femoral neck BMD across all subjects (r=0.36 p<0.001)and for men and women separately (r=0.41 for men and
0.45 for women p<0.023 and P<0.001 respectively).
Neither the hip axis length, femoral neck length nor
femoral neck width showed any difference between
groups (Table 1). Femoral neck length and hip axis
length correlated strongly with femoral neck width
(r= 0.71 and 0.78 respectively, both p<0.001) suggesting
these are measures of bone size and perhaps subject size.
The correlations for each gender separately were also
highly significant with coefficients of around 0.64. Both
hip length measurements and the neck width correlated
with the sum of vertebral body heights in the hip fracture
only female patients (there being too few men for mean-
ingful analysis), this being the group without vertebral
damage, again suggesting this is a patient size issue (for
femoral neck length, r=0.48, p<0.001; for hip axis length
r=0.46 p=0.002 and for femoral neck width, r=0.44
p=0.004). Interestingly the cortical bone thickness was not
correlated with any of the size measurements, suggesting
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Figure 1 Mean Lumbar BMD T-Scores and Z-Score. Legend: “gray shading” BMD T-Scores, “dark gray shading” BMD Z-Scores. * indicates
significant differences between the 'Only Spinal Fractures' group and 'Spinal and the ‘Hip Fractures' group (p=0.002; 0.002; 0.016). + indicates
significant differences between the 'Only Spinal Fractures' group and the ‘Only Hip Fractures' group (p=0.000; 0.000; 0.001).
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those with a width which was relatively low compared to
length (that is, a long and narrow neck) that are at risk
but there was no difference between the groups.
When the BMD for the femoral neck is plotted on the
CAROC graphs (3) of femoral neck t-score against age
approximately one quarter of patients were of an age
that was beyond the graphs’ limits. However, we
attempted to extrapolate the graphs beyond the 85 year































Figure 2 Infero-medial Femoral Neck Cortical Bone Thickness. * indica
and the 'Spinal and Hip Fractures' group (p=0.000). + indicates significant d
Fractures' group (p=0.040).fracture (approximately one third) and one out of every
20 men fell, on the basis of BMD alone, into the high
risk category. Interestingly, the presence of spinal
fractures did not increase the proportion of hip fracture
patients falling into the high risk category when defined
by the femoral neck t-score. For those with spinal frac-
ture alone, only 14 (13 female and 1 male) fell into the
high risk zone on the CAROC graph. On the other hand,
of those with spinal fractures alone, 50% fell below a




Only Hip Fractures (N=50)
*
+
tes significant differences between the 'Only Spinal Fractures' group
ifferences between the 'Only Spinal Fractures' group and the ‘Only Hip
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fracture alone. For a femoral neck t-score of −2.5, the
respective numbers are 60%, 43% and 45% respectively.
The location and severity of vertebral fractures
Patients presenting with spinal fractures have a higher
number of spinal fractures than those with hip fracture
and spinal fractures (165 vs. 138 respectively) and as a
result both the spinal deformity index and the spinal
fracture index are higher in the vertebral fracture alone
group (5.80+/− 3.44 vs 4.25 +/− 2.50 and 0.43+/−0.26 vs.
0.327+/−0.19, respectively, p=0.029 for both) but the in-
dividual fractures are of similar severity (1.728 vs. 1.66
ns.). However, as shown in Figure 3, both groups seem
to follow the same bimodal trend with the majority of
fractures seen in the mid-thoracic region (T6-T8) and
the thoracic/lumbar junction (T12-L1).
Discussion
This study compared three groups of fracture patients:
those with spinal fractures and no hip fractures, those
with both spinal and hip fractures and those with hip
fractures and no spinal fractures. Our analysis has
attempted to sort out the relative contributions of tra-
becular and cortical bone deficiency to the different
fractures and we were particularly interested to see if the
presence of vertebral fractures in the ihip fracture popu-
lation might identify a group with deficient trabecular
bone and so be a group who could be responsive to
treatment, as opposed to being a group in whom the
presence of vertebral fractures was simply another re-
flection of their falling and hence more traumatic in na-
ture. Patients presenting to the osteoporosis clinic with
spinal fractures have generally more deficient bones than
those of similar age presenting with hip fractures, in-
cluding a tendency to a lower hip density. In most
























Figure 3 Number of Fractures by Vertebral location. Legend: “gray sha
Hip Fractures.lowest bones mass and the hip fracture patients without
spinal fractures the highest and those with both spinal
and hip fracture in between. This is clear for the spinal
density but a similar, though less marked, trend is seen
for the hip density measurements that reflect trabecular
bone, and less again for the cortical site of the neck of
femur. Additionally, patients presenting with spinal
fractures only, tend to have both a higher number of
spinal fractures than those presenting with a hip fracture
and spinal fractures, although the severity of the individ-
ual fractures and the distribution of the fractures in the
spine is similar. The bimodal trend of fracture location
with an increased frequency around T7-T8 and another
peak around T12-L1 is consistent with previous findings
[16]. This pattern was not affected by the presence of
hip fractures. We had hypothesised that if the vertebral
fractures had been more related to trauma (falling) in
the hip fracture population, there might have been a
trend towards more fractures in the lower spine, the site
most vulnerable to traumatic damage [13]. This appears
not to be the case. These patients appear to have tra-
becular osteoporosis though perhaps of a milder degree
than the spinal fracture only patients.
Most studies evaluating the effectiveness of osteopor-
osis medications have focused on patients with poor
trabecular bone, as reflected in low spinal density, with
or without spinal fractures, and treated them with
antiresorptives which are known to mostly act on tra-
becular bone. In general the effect on the prevention of
further vertebral fractures has been impressive while the
effect on non-vertebral fractures has been less so. Few
studies have focused directly on the prevention of non-
vertebral fractures in less selected patients and those
that have, have not been very successful. Black and
colleagues showed the presence of prevalent vertebral
fractures indicated a high risk for future hip fracture
whereas in the study conducted by McClung, theT10 T11 T12 L1 L2 L3 L4
racture Location
ding” Only Spinal Fractures, “dark gray shading” Spinal Fractures and
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treatment if the patients had no prevalent vertebral
fractures [17,18]. Likewise, recruiting older (>80 year
old) patients on the basis of falling risk, with, in most
cases, no reference to bone density, and treating with
risedronate, had little effect on subsequent hip fracture
rate [18]. Although some of these patients had reduced
bone density this was femoral neck bone density, a
measure of cortical bone, and there was no significant
reduction in femoral fracture with treatment.
It also appears that recruiting patients on the basis of
a prior hip fracture without regard to trabecular bone
status has limited benefit in the prevention of further
hip fractures. For example, the zoledronic acid study of
fracture prevention in hip fracture patients showed
greater ability to prevent further (clinical) spine fractures
and a more modest and non-significant benefit in the
prevention of further hip fractures [19]. Unfortunately
the spinal state of these patients at the start of the study
is unknown. In the other study with zoledronic acid, the
fracture prevention study, although the bone density
qualification for the study was on the basis of the fem-
oral neck measurement, 63% had baseline vertebral
fractures suggesting significant prevalence of trabecular
bone deficiency, and a reduction in hip fractures was
seen [20].
If it is true that the presence or absence of trabecular
bone mass reduction has an influence on the likelihood
of response to treatment, it does not mean that trabecu-
lar bone loss is required for a hip fracture to occur, it
simply increases the risk and may influence the type of
fracture that occurs. Although the definition of osteo-
porosis has evolved to a risk paradigm, the notion of a t-
score of −2.5 representing a significantly low BMD has
to some extent survived, particularly at the spine site [3].
Only a minority of our patients with a hip fracture had a
spinal BMD t-score below this osteoporotic threshold,
even fewer if there were no spinal fractures. Our sample
is not random, and is in fact biased toward the spinal
fracture subjects, as the presence of spinal fractures in
the hip fracture population is likely less than the 50% we
selected here. Nonetheless, using spinal BMD and a cut
point of t-score of −2.5 only 30% of those with hip and
spinal fractures and 18% of those with hip fracture with-
out spinal fractures fell below that point, while 50% of
those with spinal fractures alone did so. In addition we
find that most women and all men in our study would
not have been in the high risk category using the
CAROC paradigm on the basis of femoral neck BMD
alone although the CAROC graph for men is unusual in
showing no age-related rise in fracture risk. We were
not able to calculate prior risk on the FRAX model as
we had not gathered the extra information required by
that model. These observations are similar to thosereported by others, and the observations of Stone and
colleagues who found low bone density to explain only a
modest number of fractures [21-23]. These observations
speak against the automatic labelling of hip fracture
patients as osteoporotic and presumably reflect the large
number of outcomes (hip fractures) that originate in the
larger population of people at relatively low or moderate
risk, have fairly good bones, but fall in such a way as to
endanger the integrity of the hip bone. Although the ab-
solute risk in such patients is low, their greater numbers
likely ensure they contribute substantially to the overall
hip fracture numbers but treatment of such low risk
subjects may not be of value as far as the hip fracture
prevention is concerned. Certainly treating those with
relatively good femoral neck bone density was of no
benefit [24]. If preventing a hip fracture in such patients
with bisphosphonates is relatively unsuccessful then
preventing a second hip fracture in such patients is also
likely to be unsuccessful.
A prior “fragility fracture” is certainly associated with
an increased risk of a further one, but this may be on
the basis of a risk of recurrent falling. If there is no sec-
ond fall, there will be no second fracture. Of note is the
finding that the increased risk of a second fracture in
those who have experienced a first fragility fracture, is
largely independent of bone density, and even more so
in older age, pointing to falling as the predominant risk
factor [25]. Likewise in their study of the time for people
with a certain bone density at the hip to cross the osteo-
porosis threshold, Gourley found that the presence of a
prior fracture had no effect [26].
It is notable that in our study the z-scores in the hip
fracture patients without spinal fracture are normal (that
is, above or close to zero) indicating no greater deficiency
in skeletal mass in these patients than in the age and
gender matched normative databases of the particular
densitometers (Table 1). Given the dynamics of falling in
old age, with a greater tendency to fall from a static pos-
ition backwards on to the greater trochanter, it may be
that all older people are at risk of a hip fracture should
they fall in this manner. However those with trabecular
bone deficiency will be at higher risk as the trabecular
bone contributes 50% of the hip mass. The relative degree
of loss of trabecular versus cortical bone loss may be im-
portant in determining the nature of the hip fracture.
Thus the intertrochanteric site has more trabecular bone
than the subcapital site and patients with IT fractures have
lower spinal density [27]. It has been suggested that lower
trabecular bone mass places the intertrochanteric site at
risk, and, as it collapses more readily, this protects the
subcapital site from the transmitted force [28]. Other
studies have found that femoral neck length was greater in
those who suffered a subcapital fracture [29-32]. Our data
suggests this may be related simply to greater person
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body heights are related. Taller people may be at more risk
of a hip fracture in a fall with trauma, rather than bone de-
ficiency, being the predominant cause and leading to a
greater tendency to subcapital fractures [33]. Our study
suggests that these architectural considerations are inde-
pendent of the presence or otherwise of trabecular bone
status.
A potential weakness of the study is that the patients
with hip fracture are a selected group of convenience.
Patients missed, as noted above, are those who are
younger and go directly home and those who go directly
to LTC, who tend to be older. However as our compari-
son is with elderly ambulatory osteoporotic patients
attending the osteoporosis clinic, the exclusion of a
younger group, and an older, particularly frail group, is
not inappropriate. Our study includes both genders on
the assumption that hip fractures in either sex will show
similar deficiencies regardless of gender. Although there
are more women in the group with hip fracture and no
spinal fracture, the analysis shows this to be group with
the best bones, a finding which would be biased against
by a predominance of women. On the other hand the
spinal fracture alone group were slightly younger, but
they turned out to have the most deficient bones. The
analysis was re-run on the women alone. The smaller
numbers made some comparisons fall below the signifi-
cance level but overall the trends were unchanged.Conclusion
It appears that the risk of a hip fracture is a complex
interaction of falling, person height, hip architecture and
cortical and trabecular bone status, varying com-
binations of which determine the risk overall and, per-
haps, the particular type of hip fracture sustained. It may
be that only one of these factors, trabecular bone status,
predicts a response to the current antiresorptives which
are predominantly active on trabecular bone and the
presence of vertebral fractures may be a simple indicator
of such a state. More detailed reporting of the ran-
domized controlled studies, in particular regarding the
trabecular and spinal fracture status and the nature of
the hip fractures that occur and the different responses
to treatment in these various sub-groups, might bring
better understanding of this phenomenon.Competing interests
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